Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Clinical trial NCT02909972 · COMPLETED
Trial details
- NCT number
- NCT02909972
- Sponsor
- Aileron Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-04-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.